IS4321A - New dialkoxy-pyridinyl-benzimidazole derivatives - Google Patents

New dialkoxy-pyridinyl-benzimidazole derivatives

Info

Publication number
IS4321A
IS4321A IS4321A IS4321A IS4321A IS 4321 A IS4321 A IS 4321A IS 4321 A IS4321 A IS 4321A IS 4321 A IS4321 A IS 4321A IS 4321 A IS4321 A IS 4321A
Authority
IS
Iceland
Prior art keywords
dialkoxy
pyridinyl
new
benzimidazole derivatives
benzimidazole
Prior art date
Application number
IS4321A
Other languages
Icelandic (is)
Inventor
Lennart Lindberg Per
Elisabeth Sundén Gunnel
Oskar Sverker Von Unge Per
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of IS4321A publication Critical patent/IS4321A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IS4321A 1994-05-27 1996-01-17 New dialkoxy-pyridinyl-benzimidazole derivatives IS4321A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9400511 1994-05-27
PCT/SE1995/000519 WO1995032959A1 (en) 1994-05-27 1995-05-11 Novel dialkoxy-pyridinyl-benzimidazole derivatives

Publications (1)

Publication Number Publication Date
IS4321A true IS4321A (en) 1996-01-17

Family

ID=20392945

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4321A IS4321A (en) 1994-05-27 1996-01-17 New dialkoxy-pyridinyl-benzimidazole derivatives

Country Status (18)

Country Link
EP (1) EP0712401A1 (en)
JP (1) JPH09504557A (en)
CN (1) CN1128997A (en)
AU (1) AU2633095A (en)
BR (1) BR9506235A (en)
CA (1) CA2166988A1 (en)
CZ (1) CZ24396A3 (en)
EE (1) EE9600011A (en)
FI (1) FI960367L (en)
HU (1) HU9600005D0 (en)
IL (1) IL113604A0 (en)
IS (1) IS4321A (en)
MA (1) MA23563A1 (en)
NO (1) NO960268D0 (en)
PL (1) PL312692A1 (en)
TN (1) TNSN95062A1 (en)
WO (1) WO1995032959A1 (en)
ZA (1) ZA954125B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9423970D0 (en) * 1994-11-28 1995-01-11 Astra Ab Oxidation
GB9423968D0 (en) * 1994-11-28 1995-01-11 Astra Ab Resolution
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
PT1131316E (en) * 1998-11-18 2004-10-29 Astrazeneca Ab IMPROVED CHEMICAL PROCESS AND PHARMACEUTICAL FORMULA
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CA2667682A1 (en) 2006-10-27 2008-05-15 The Curators Of The University Of Missouri Compositions comprising acid labile proton pump inhibiting agents, at least one other pharmaceutically active agent and methods of using same
JP2011512416A (en) 2008-02-20 2011-04-21 ザ・キュレイターズ・オブ・ザ・ユニバーシティー・オブ・ミズーリ Composition comprising a combination of omeprazole and lansoprazole and a buffer and method of using the same
US9220698B2 (en) 2008-09-09 2015-12-29 Pozen Inc. Method for delivering a pharmaceutical composition to patient in need thereof
KR20120030106A (en) 2009-06-25 2012-03-27 아스트라제네카 아베 Method for treating a patient at risk for developing an nsaid-associated ulcer
EP2797600A4 (en) 2011-12-28 2015-09-16 Pozen Inc Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991019712A1 (en) * 1990-06-20 1991-12-26 Aktiebolaget Astra Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use
DE4035455A1 (en) * 1990-11-08 1992-05-14 Byk Gulden Lomberg Chem Fab ENANTIOMER SEPARATION

Also Published As

Publication number Publication date
AU2633095A (en) 1995-12-21
TNSN95062A1 (en) 1996-02-06
JPH09504557A (en) 1997-05-06
FI960367A0 (en) 1996-01-26
WO1995032959A1 (en) 1995-12-07
HU9600005D0 (en) 1996-03-28
NO960268L (en) 1996-01-23
MA23563A1 (en) 1995-12-31
CA2166988A1 (en) 1995-12-07
FI960367A7 (en) 1996-01-26
CZ24396A3 (en) 1996-06-12
EP0712401A1 (en) 1996-05-22
IL113604A0 (en) 1995-08-31
NO960268D0 (en) 1996-01-23
PL312692A1 (en) 1996-05-13
FI960367L (en) 1996-01-26
EE9600011A (en) 1996-04-15
BR9506235A (en) 1997-08-12
ZA954125B (en) 1995-11-27
CN1128997A (en) 1996-08-14

Similar Documents

Publication Publication Date Title
FI954829L (en) Aroylpiperidine derivatives
NO952854D0 (en) 1-arylpyrimidin derivatives
DE59508427D1 (en) 3-ARYL-4-HYDROXY-DELTA 3 -DIHYDROTHIOPHENONE DERIVATIVES
FI972194L (en) New benzylpyrimidines
DK0901474T3 (en) Arylpyrimidine derivatives
ATE261942T1 (en) 6-PHENYLPYRIDINE DERIVATIVES
IS1902B (en) New 19-nor-pregnene derivatives
DE69732576D1 (en) TETRAHYDROBENZINDOLON DERIVATIVES
DE69430587D1 (en) PYRIMIDINE-ACYCLONUKLEOSID DERIVATIVES
FI953710L (en) New pyrrolocarbazoles
BR9509793A (en) Thiophenene derivatives
FI971227L (en) Pyramidinylpyrazole derivatives
FI960367A7 (en) New dialkoxypyridinylbenzimidazole derivatives
EE9900182A (en) 2-methoxyphenylpiperazine derivatives
DE69527786D1 (en) DIAMINOMETHYLIDES DERIVATIVES
FI964853L (en) Deacetoxytaxol derivatives
NO970144L (en) Trifluoromethylquinolinecarboxylic derivative
DE69510792D1 (en) NAPHTOCHINONE DERIVATIVES
DE59509209D1 (en) DIPHENYLOXAZOLINE DERIVATIVES
FI955026A7 (en) Alkyl-5-methylsulfonylbenzoylguanidine derivatives
BR9509877A (en) New pyrimidinyloxy-and pyridimidinylamino-ethylphenyl-dioxolane derivatives
FI965181L (en) Polyalcohol-peptide derivatives
FI963122A7 (en) Carbamoylmethylurea derivatives
BR9506613A (en) Phenylthiooxazolines derivatives
BR9508450A (en) N-alkoxy-amidine derivatives